Home Cart Sign in  
Chemical Structure| 87081-35-4 Chemical Structure| 87081-35-4

Structure of Leptomycin B
CAS No.: 87081-35-4

Chemical Structure| 87081-35-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Leptomycin B is an inhibitor of the nuclear export of proteins which acts by binding directly to and inhibiting CRM1/exportin-1. Leptomycin B inhibits the nuclear export of the HIV regulatory protein Rev and stabilizes p53, showing antiviral, antibiotic, antifunal and antitumor in vitro and in vivo.

Synonyms: CI 940; LMB; NSC 364372

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Leptomycin B

CAS No. :87081-35-4
Formula : C33H48O6
M.W : 540.73
SMILES Code : O=C(O)/C=C(C)/C[C@H](C)[C@@H](O)[C@H](C)C([C@H](C)/C=C(C)/C=C/C[C@@H](C)/C=C(CC)\C=C\[C@H]1[C@@H](C)C=CC(O1)=O)=O
Synonyms :
CI 940; LMB; NSC 364372
MDL No. :MFCD06795848

Safety of Leptomycin B

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H319-H332-H361
Precautionary Statements:P210-P280-P305+P351+P338-P308+P313

Isoform Comparison

Biological Activity

Description
Leptomycin B (CI 940; LMB) is a potent inhibitor of protein nuclear export, inactivating CRM1/exportin 1 through covalent modification at a cysteine residue. It has been identified as a potent antifungal antibiotic that impedes the eukaryotic cell cycle[1].

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293 20 ng/mL 5 to 6 hours Inhibition of CRM1 function results in nuclear accumulation of miRNA guide sequences PMC2787469
HeLa cells 10 nM 2 hours To detect the binding of LMB to CRM1, results showed that LMB specifically binds to CRM1. PMC17741
HCT116 20 ng/mL 5 to 6 hours Inhibition of CRM1 function results in nuclear accumulation of miRNA guide sequences PMC2787469
HeLa cells 100 ng/ml 10 hours To investigate the nuclear egress of full canine parvovirus (CPV) capsids when CRM1-mediated nuclear export is inhibited. Results showed that LMB treatment could not fully inhibit the nuclear egress of capsids, suggesting the existence of CRM1-independent pathways. PMC9773396
NLFK cells 100 ng/ml 10 hours To investigate the nuclear egress of full canine parvovirus (CPV) capsids when CRM1-mediated nuclear export is inhibited. Results showed that LMB treatment could not fully inhibit the nuclear egress of capsids, suggesting the existence of CRM1-independent pathways. PMC9773396
HeLa cells 40 ng/ml 15 hours To verify the inhibition of CRM1-dependent RNA export pathway by Leptomycin B and identify RNA targets dependent on HuR for nuclear export. PMC8887463
HeLa cells 500 nM 15 minutes To study the effect of Leptomycin B on PKI nuclear export, results showed that Leptomycin B at 500 nM inhibited Crm1-dependent PKI nuclear export. PMC2193655
T22 RGC Dfos-lac Z cells less than nanomolar concentrations 16 hours To study the induction of p53-dependent transcriptional activity by LMB, demonstrating the potency of LMB as an inducer of the p53-dependent transcriptional activity. PMC2377168
H1299 cells 2 nM 18 hours To study the effect of LMB on hMdm2, observing two novel forms of hMdm2: a slow-mobility form and a 32 kDa N-terminal fragment. PMC2377168
U2OS cells 2 nM 18 hours To study the effect of LMB on hMdm2, observing two novel forms of hMdm2: a slow-mobility form and a 32 kDa N-terminal fragment. PMC2377168
Swiss 3T3 cells 200 nM 20 minutes To investigate the inhibitory effect of Leptomycin B on nuclear export of GFP-MK2, results showed that LMB completely reversed the cytoplasmic localization of GFP-MK2-T205,317E and GFP-C-term, relocating them to the nucleus. PMC1170674
SiHa cells 50 nM 24 h Inhibited nuclear export of HP1γ, increased p53 signaling, decreased UBE2L3 expression, and enhanced cisplatin sensitivity PMC7503686
NIH3T3 cells 20 nM 24 hours To confirm the effect of Leptomycin B on nuclear accumulation of LC3 in NIH3T3 cells, results were consistent with those in hTM cells. PMC7469449
Human trabecular meshwork (hTM) cells 20 nM 24 hours To investigate the effect of Leptomycin B on nuclear accumulation of LC3, results showed that Leptomycin B treatment led to the formation of prominent nuclear LC3 aggregates. PMC7469449
HEK293 cells 5 nM 6 hours Inhibition of Ku70 nuclear export and IFN-λ1 induction PMC8207419
MDCK II 100 nM 24 hours To study the effects of NEI on MDCK II cells. Results showed that NEI induced more prominent mesenchymal characteristics while retaining some epithelial features. PMC9943065
MCF10A 100 nM 24 hours To investigate the effects of nuclear export inhibition on collective migration and epithelial-mesenchymal states in MCF10A cells. Results showed that NEI enhanced both epithelial (e.g., increased p120 and ZO-1 expression) and mesenchymal (e.g., nuclear YAP localization and vimentin expression) characteristics, leading to a concurrent epithelial-mesenchymal state. PMC9943065
BHK cells 200 nM 26 hours To study the effect of Leptomycin B on GR nuclear export, results showed that Leptomycin B at 200 nM did not affect GR nuclear export. PMC2193655
WT human dermal fibroblasts 1 nM 3 days To evaluate the effect of LMB on mitochondrial function, results showed no significant changes in mitochondrial function in WT cells PMC9856861
HGPS-2 human dermal fibroblasts 1 nM 3 days To evaluate the effect of LMB on mitochondrial function, results showed that LMB treatment restored mitochondrial morphology, membrane potential, and ATP levels, and reduced ROS accumulation PMC9856861
HGPS-1 human dermal fibroblasts 1 nM 3 days To evaluate the effect of LMB on mitochondrial function, results showed that LMB treatment restored mitochondrial morphology, membrane potential, and ATP levels, and reduced ROS accumulation PMC9856861
HEK293 cells 20 nM 3 hours Verify interactions of ADD proteins with nuclear export proteins (e.g., CRM1 and exportin5) PMC5424492
NIH3T3 cells 20 nM 3 hours Inhibits CRM1/exportin1-mediated nuclear export, resulting in partial (~40%) nuclear retention of ADD2 and ADD3 PMC5424492
Schizosaccharomyces pombe (S. pombe) 50 ng/ml 6 hours To detect the inhibitory effect of LMB on nuclear export, results showed that LMB inhibits the nuclear export function of wild-type CRM1 but has no effect on the Crm1-K1 mutant. PMC17741
Human A549 pulmonary epithelial cells 20 nM 60 min Blocking Ad5 nuclear pore targeting, dramatically increased centrosome accumulation of incoming Ad5 capsids within the first 30 min post infection PMC5983873

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.85mL

0.37mL

0.18mL

9.25mL

1.85mL

0.92mL

18.49mL

3.70mL

1.85mL

References

 

Historical Records

Categories